Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBPH | AKBA | KALV | ||
| Company | Theravance Bio Ord | Akebia Therapeutics | Kalvista Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.45 | 2.13 | 10.20 | ||
| High | 9.84 | 2.17 | 10.20 | ||
| Low | 9.37 | 2.01 | 9.71 | ||
| Last | 9.84 | 2.04 | 9.73 | ||
| Change | +0.40 | -0.09 | -0.54 | ||
| % Change | +4.24% | -4.23% | -5.26% | ||
| Volume | 240,400 | 3,342,600 | 216,600 | ||
| 20-Day Average Volume | 240,685 | 2,460,330 | 451,045 | ||
| Previous Close | 9.44 | 2.13 | 10.27 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.33 | 1.93 | 10.19 | ||
| 20-Day Raw Stochastic | 80.20% | 74.00% | 29.08% | ||
| 20-Day Relative Strength | 61.88% | 64.06% | 42.72% | ||
| Weighted Alpha | +1.13 | +44.13 | -8.70 | ||
| Today's Opinion | 56% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 40% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.91% since 11/25/24 | +5.70% since 11/25/24 | -3.38% since 11/25/24 | ||
| Low | 9.14 on 12/02/24 | 1.90 on 11/26/24 | 9.68 on 11/26/24 | ||
| High | 9.84 on 12/03/24 | 2.17 on 12/03/24 | 10.48 on 12/02/24 | ||
| 1-Month | |||||
| %Chg | +18.84% since 11/01/24 | +20.71% since 11/01/24 | -8.29% since 11/01/24 | ||
| Low | 8.14 on 11/05/24 | 1.67 on 11/07/24 | 8.75 on 11/21/24 | ||
| High | 10.26 on 11/13/24 | 2.17 on 12/03/24 | 12.85 on 11/04/24 | ||
| 3-Month | |||||
| %Chg | +23.00% since 09/03/24 | +44.68% since 09/03/24 | -21.34% since 09/03/24 | ||
| Low | 7.88 on 10/09/24 | 1.24 on 10/01/24 | 8.75 on 11/21/24 | ||
| High | 10.26 on 11/13/24 | 2.17 on 12/03/24 | 13.14 on 09/06/24 | ||
| 6-Month | |||||
| %Chg | +15.36% since 06/03/24 | +78.95% since 06/03/24 | -19.65% since 06/03/24 | ||
| Low | 7.44 on 08/09/24 | 0.80 on 06/26/24 | 8.75 on 11/21/24 | ||
| High | 10.42 on 07/26/24 | 2.17 on 12/03/24 | 15.50 on 07/24/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 464,202 | 464,726 | 443,818 | ||
| Shares Outstanding, K | 49,174 | 218,181 | 43,215 | ||
| Annual Sales | 57,420,000 | 194,620,000 | 0 | ||
| Annual Net Income | -55,190,000 | -51,930,000 | -126,640,000 | ||
| Last Quarter Sales | 16,870,000 | 37,430,000 | 0 | ||
| Last Quarter Net Income | -12,700,000 | -20,040,000 | -40,440,000 | ||
| 60-Month Beta | 0.23 | 0.70 | 0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/12/24 | -0.10 on 11/07/24 | -0.87 on 09/05/24 | ||
| Latest Earnings Date | 11/12/24 | 11/07/24 | 12/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||